Yuqi J. Jiang

16 Jiangsu Road
Qingdao, 266003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Design, synthesis, and anti-inflammatory evaluation of novel N-(Benzol[d]oxazol-5-yl)sulfonamides as NLRP3 inflammasome inhibitors.

Design, synthesis, and anti-inflammatory evaluation of novel N-(Benzol[d]oxazol-5-yl)sulfonamides as NLRP3 inflammasome inhibitors.

Journal: Bioorganic chemistry

Published: February 15, 2026

Mapping Steroidogenic Perturbations Under Endocrine Disruptor Mixtures Across Demographic Subgroups: Structural and Metabolomic Insights.

Mapping Steroidogenic Perturbations Under Endocrine Disruptor Mixtures Across Demographic Subgroups: Structural and Metabolomic Insights.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 29, 2026

Design, Synthesis, and Anti-inflammatory Activity Evaluation for Hydrazide-Based HDAC6 Targeted Protein Degraders.

Design, Synthesis, and Anti-inflammatory Activity Evaluation for Hydrazide-Based HDAC6 Targeted Protein Degraders.

Journal: Journal of medicinal chemistry

Published: November 11, 2025

Breaking the Activity-Stability Trade-off in Acidic OER via Mechanism Switching on Mo-Doped RuO2.

Breaking the Activity-Stability Trade-off in Acidic OER via Mechanism Switching on Mo-Doped RuO2.

Journal: Precision chemistry

Published: November 04, 2025

Design, synthesis, and biological evaluation of novel HDAC3 PROTACs for combined therapy with Venetoclax in acute myeloid leukemia.

Design, synthesis, and biological evaluation of novel HDAC3 PROTACs for combined therapy with Venetoclax in acute myeloid leukemia.

Journal: Bioorganic chemistry

Published: September 03, 2025

Development of Hydrazide-Based HDAC6 Selective Inhibitors for Treating NLRP3 Inflammasome-Related Diseases.

Development of Hydrazide-Based HDAC6 Selective Inhibitors for Treating NLRP3 Inflammasome-Related Diseases.

Journal: Journal of medicinal chemistry

Published: April 07, 2025

Antitumor effect of BC12-3 on multiple myeloma via proteasome inhibition.

Antitumor effect of BC12-3 on multiple myeloma via proteasome inhibition.

Journal: Medical oncology (Northwood, London, England)

Published: February 28, 2025

Discovery of hydrazide-based PI3K/HDAC dual inhibitors with enhanced pro-apoptotic activity in lymphoma cells.

Discovery of hydrazide-based PI3K/HDAC dual inhibitors with enhanced pro-apoptotic activity in lymphoma cells.

Journal: European journal of medicinal chemistry

Published: February 12, 2025

Design, synthesis, and anti-cancer evaluation of the novel conjugate of gemcitabine's ProTide prodrug based on CD13.

Design, synthesis, and anti-cancer evaluation of the novel conjugate of gemcitabine's ProTide prodrug based on CD13.

Journal: Bioorganic chemistry

Published: January 13, 2025

Advancing anti-freezing hydrogel electrolyte based on deep eutectic solvent for wide temperature range aqueous zinc-ion battery.

Advancing anti-freezing hydrogel electrolyte based on deep eutectic solvent for wide temperature range aqueous zinc-ion battery.

Journal: Journal of environmental sciences (China)

Published: October 09, 2024

Design, synthesis and biological evaluation of novel diphenylamine analogues as NLRP3 inflammasome inhibitors.

Design, synthesis and biological evaluation of novel diphenylamine analogues as NLRP3 inflammasome inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: July 07, 2024

Design, synthesis, and biological activity evaluation of novel HDAC3 selective inhibitors for combination with Venetoclax against acute myeloid leukemia.

Design, synthesis, and biological activity evaluation of novel HDAC3 selective inhibitors for combination with Venetoclax against acute myeloid leukemia.

Journal: European journal of medicinal chemistry

Published: May 08, 2024

Showing 1-12 of 52

Last Updated: 09/26/2026